A lthough in-hospital cardiac arrest in children is associated with poor survival, the extent to which survival rates differ across hospitals is unknown. 1 Understanding this interhospital variation is important, as the presence of substantial variability would suggest an opportunity to improve pediatric outcomes after cardiac arrest. To that end, The Joint Commission and other national organizations, such as the American Heart Association, are developing performance measures to benchmark outcomes for in-hospital cardiac arrest and resuscitation.
Methods

Study Population
Formerly known as the National Registry of Cardiopulmonary Resuscitation, GWTG-Resuscitation is a large, prospective, national registry of in-hospital cardiac arrest sponsored by the American Heart Association. Its design has been described in detail previously. 3 In brief, trained hospital personnel enroll all patients without do-notresuscitate orders with a cardiac arrest (defined as pulselessness requiring either chest compressions or defibrillation or both and eliciting a hospital-wide or unit-based emergency response). Cases are identified by multiple methods, including centralized collection of cardiac arrest flow sheets, reviews of hospital paging system logs, and routine checks of code carts, pharmacy tracer drug records, and hospital billing charges for resuscitation medications. 3 Standardized Utstein-style definitions are used for all patient variables and outcomes to facilitate uniform reporting across hospitals. 4, 5 In addition, data accuracy is ensured by rigorous certification of hospital staff and use of standardized software with data checks for completeness and accuracy. 3 Currently, the Registry incorporates data from ≈8% of all US hospitals.
From January 2000 through August 2010, data from 2883 pediatric patients under 18 years of age with an in-hospital cardiac arrest were submitted to GWTG-Resuscitation. Because pediatric in-hospital survival rates have improved over time, 6 we restricted our study sample to the 1640 patients enrolled between January 2006 and August 2010 to ensure that our risk models were based on a contemporary cohort of patients. Additionally, we excluded 89 resuscitations performed in the delivery room, as cardiac arrests in the delivery room differ physiologically and mechanistically from cardiac arrests in other hospital settings. Our final study cohort comprised 1551 patients from 164 hospitals.
Study Outcome and Variables
The primary outcome of interest was survival to hospital discharge. Several baseline characteristics were screened as candidate predictors for the study outcome. Variables that were considered for model inclusion were those clinical and demographic characteristics that were known to be associated with survival. These included age at the time of cardiac arrest (categorized as neonates [≤30 days], infants [31 days to ≤1 year], young children [1-8 years] , and older children [>8 years of age]), sex, location of arrest (categorized as procedure areas, intensive care, monitored unit, nonmonitored unit, emergency department, and other), time of arrest (day versus night [11:00 PM to 6:59 AM]), 7 initial cardiac arrest rhythm (ventricular fibrillation, pulseless ventricular tachycardia, asystole, pulseless electric activity), and illness category (medical-cardiac, medical-noncardiac, surgical-cardiac, surgical-noncardiac).
In addition, the following comorbidities or medical conditions coded as present prior to cardiac arrest were evaluated for the model: heart failure; renal, hepatic, or respiratory insufficiency; baseline evidence of motor, cognitive, or functional neurological deficits (central nervous system depression); acute stroke; acute nonstroke neurological event; pneumonia; hypotension; arrhythmia; sepsis; major trauma; metabolic or electrolyte abnormality; and metastatic or hematologic malignancy. Finally, we considered for model inclusion several critical care interventions (requirement for mechanical ventilation, intravenous vasoactive medications, or intravenous antiarrhythmics) already in place at the time of cardiac arrest. Race was not considered for model inclusion, as prior studies have found that racial differences in survival after in-hospital cardiac arrest are partly mediated by differences in hospital care quality for blacks and whites. 8, 9 
Model Development and Validation
Multivariable logistic regression models were constructed to identify significant predictors of in-hospital survival. Because our primary objective was to derive risk-standardized survival rates for each hospital, which would require accounting for clustering of observations within hospitals, we used hierarchical logistic regression models for our analyses. 10 By using hierarchical models to estimate the log-odds of in-hospital survival as a function of demographic and clinical variables (both fixed effects) and a random effect for each hospital, we were able to assess hospital variation in risk-standardized survival rates after accounting for patient case-mix.
We considered for model inclusion the candidate variables described in the previous section. Age group, sex, initial cardiac arrest rhythm, and arrest location were included in the model regardless of statistical significance. Multicollinearity between covariates was assessed for each variable prior to model inclusion. 11 Model discrimination was assessed with the C-statistic, which quantifies the receiver operating characteristic curve of the model. 12 To validate the model, we examined observed versus predicted plots and performed 1000 bootstrap samples to derive a validation C-statistic that would correct for potential model overfitting. 13
Hospital Risk-Standardized Survival Rates
Using the hospital-specific estimates (ie, random intercepts) from the hierarchical models, we then calculated risk-standardized survival rates for the 30 study hospitals with a minimum of 10 cardiac arrest cases by multiplying the registry's unadjusted survival rate by the ratio of a hospital's predicted to expected survival rate. We used the ratio of predicted to expected outcomes (described below) instead of the ratio of observed to expected outcomes to overcome analytic issues that have been described for the latter approach. [14] [15] [16] Specifically, our approach ensured that all hospitals, including those with smaller case volumes, would have appropriate risk-standardization and confidence intervals for their cardiac arrest survival rates.
For these calculations, the expected hospital number of cardiac arrest survivors is the number of cardiac arrest survivors expected at the hospital if the hospital's patients were treated at a reference hospital (ie, the average hospital-level intercept from all hospitals in GWTG-Resuscitation). This was determined by regressing patients' risk factors and characteristics on in-hospital survival with all hospitals in the sample, and then applying the subsequent estimated regression coefficients to the patient characteristics observed at a given hospital, and then summing the expected number of deaths. In effect, the expected rate is a form of indirect standardization. In contrast, the predicted hospital outcome is the number of survivors at a specific hospital. It is determined in the same way that the expected number of deaths is calculated, except that the hospital's individual random effect intercept is used. The risk-standardized survival rate was then calculated by multiplying the ratio of predicted to expected survival rate by the unadjusted rate for the entire study sample. 17 The effects
WHAT IS KNOWN
• Pediatric in-hospital cardiac arrest is associated with poor survival.
WHAT THE STUDY ADDS
• Substantial site-level variation in survival for pediatric in-hospital cardiac arrest exists prior to risk adjustment. This variation was attenuated after riskstandardization for patient case-mix, highlighting the importance of adjusting for patient factors in sitelevel comparisons for this condition. • Despite risk-standardization, hospital variation in survival for pediatric in-hospital cardiac arrest persisted. • Futures studies can apply the risk-standardization methodology developed in this study to identify high-performing hospitals and best practices at these centers. of risk-standardization on unadjusted hospital rates of survival were then illustrated with descriptive plots and statistics. All study analyses were performed with SAS 9.2 (SAS Institute, Cary, NC) and R version 2.10.0. 18 The hierarchical models were fitted with the use of the GLIMMIX macro in SAS. Dr Chan had full access to the data and takes responsibility for its integrity. All authors have read and agree to the article as written. The study was conducted on deidentified quality improvement registry data and did not meet criteria for requirement for informed consent. The American Heart Association's GWTG-Resuscitation Committee approved the final article draft.
Results
Of the 1551 patients with in-hospital cardiac arrest, 481 (31.0%) were neonates, 358 (23.1%) infants, 358 (23.1%) younger children, and 354 (22.8%) older children. Fifty-eight percent of the study population were male and 21.5% were black. The vast majority (n=1361, 87.7%) had a nonshockable cardiac arrest rhythm: 53.8% had a first documented rhythm of pulseless electric activity and 33.9% with asystole. Sixtyseven percent of the arrests occurred in an intensive care unit and 21.4% in a procedure area or in the emergency department, with <10% occurring on a general pediatric ward. Hypotension was documented in 38.3% prior to the cardiac arrest, and respiratory insufficiency in 60.1%.
Predictors of Survival
Overall, 543 (35.0%) pediatric patients with an in-hospital cardiac arrest survived to hospital discharge. Tables 1 and 2 compare baseline demographics of the study cohort among those patients who survived and those who did not survive to hospital discharge. Children over 8 years of age were less likely to survive an in-hospital cardiac arrest than younger patients. In univariate analyses, the presence of hypotension, renal insufficiency, hepatic insufficiency, metabolic or electrolyte abnormalities, acute central nervous system nonstroke event, sepsis, major trauma, and metastatic or hematologic malignancy were also associated with a lower likelihood of survival. Finally, patients treated with mechanical ventilation and intravenous vasoactive medications at the time of cardiac arrest were less likely to survive, whereas patients treated with antiarrhythmics at the time of cardiac arrest were more likely to survive to discharge. After multivariable adjustment, 13 variables were identified as critical factors for risk-standardization (Table 3) . These included age, sex, illness category, cardiac arrest rhythm, location of arrest, mechanical ventilation, acute nonstroke neurological event, major trauma, hypotension, metabolic or electrolyte abnormalities, renal insufficiency, sepsis, and requirement for intravenous vasoactive medications at the time of arrest. The model had good discrimination (C-statistic of 0.71). Model calibration was confirmed with observed versus predicted plots (Figure 1) . For model validation, we performed a series of 1000 bootstrap samples and found that model discrimination was similar (bootstrap-corrected validation C-statistic of 0.69).
Hospital Variation in Risk-Standardized Survival Rates
Prior to adjustment for case-mix, survival rates for the 30 hospitals with ≥10 cardiac arrest cases varied considerably, with a median hospital rate of 37%, an interquartile range of 24% to 42%, and a total range of 0% to 61% (Figure 2A) . After riskstandardization, the distribution of hospital rates of survival narrowed considerably. However, some variation in hospital rates of survival persisted, with a median hospital risk-standardized rate of 37%, interquartile range of 33% to 38%, and a total range of 29% to 48% ( Figure 2B ).
Discussion
Using a large national registry, we developed and validated a risk-standardized model for survival in pediatric patients with in-hospital cardiac arrest. Among a wide range of variables, our model identified 13 unique patient predictors of survival to discharge. These variables were defined using standardized definitions and are easily obtainable from medical records. Without adjustment for patient factors, the range of survival rates across hospitals was 0% to 61%. After adjustment for patient case-mix, the range of risk-standardized hospital rates of cardiac arrest survival narrowed substantially (range=29-48%), but hospital variation in survival remained. The presence of variability in risk-standardized survival rates among hospitals suggests an opportunity to save lives if hospitals in the lower range were able to achieve survival rates of higherperforming hospitals.
Most prior studies of pediatric in-hospital cardiac arrest have focused on identifying patient predictors of survival. For instance, children whose cardiac arrest is caused by an underlying cardiac etiology have been shown to have lower survival than those with a respiratory pathogenesis. 19 Likewise, those with an arrest surrounding surgery for repair or palliation of congenital heart disease are more likely to survive than those with a medical-cardiac or noncardiac diagnosis. 20 Others have found that certain cardiac arrest rhythms, such as ventricular fibrillation and pulseless ventricular tachycardia, are associated with improved survival. 21 Despite identification of certain patient characteristics associated with survival in prior studies, there has been, to date, no validated method to risk-standardize hospital rates of survival for pediatric in-hospital cardiac arrest-a critical foundation for quality improvement. In this study, we have created and validated such a model to facilitate comparisons of pediatric outcomes for this condition between hospitals. Such a model will be of great value to benchmark hospital performance on in-hospital cardiac arrest and to guide future quality improvement efforts. Our model adhered to recommended standards for models of publicly reported outcomes, including high-quality and timely data as well as clinical coherence of the model variables. 2 Importantly, we utilized a hierarchical randomeffects model, which accounts for variation in sample size between hospitals to generate shrinkage estimates for sites with lower case volumes.
In this study, we found that the interquartile range prior to risk-adjustment was 18% and narrowed to 5% after risk adjustment. This suggests that risk-standardization is critical to future benchmarking efforts, as the interquartile range narrowed by over 70%. It also highlights that, despite a reduction in variation of survival rates across hospitals, there remained significant variability in hospital survival rates that was not attributable to differences in patient characteristics reported in the registry. This suggests that the remaining hospital variation in pediatric cardiac arrest survival may be due to hospital-specific factors including quality of care before, during, and after resuscitation. Such factors may include resuscitation response times (eg, time to defibrillation), chest compression depth, frequency of interruptions in chest compressions, duration of cardiopulmonary resuscitation, and postresuscitation care (eg, hospital differences in intensive care expertise). 1, [22] [23] [24] [25] [26] Future studies are needed to identify best practices associated with higher survival rates at high-performing hospitals and whether such practices can be readily disseminated and effectively implemented to all hospitals.
The impact of having access to a risk-standardized model for survival in pediatric patients with in-hospital cardiac arrest may be profound for quality improvement initiatives. Hospitals need to be able to benchmark the effect of their improvement programs over time, and with other organizations. Similar to other conditions that are the focus of broad quality programs such as acute myocardial infarction, 27 the field of pediatric resuscitation will greatly benefit from having validated methods to risk-standardize survival outcomes for in-hospital cardiac arrest.
Our study has certain limitations. GWTG-Resuscitation is a quality improvement registry, and hospital participation is voluntary. Given the fact that a minority of children's hospitals in the US participate in the registry and hospitals in a quality improvement registry are more likely to direct substantial resources to improving cardiopulmonary resuscitation outcomes, our findings may not be generalizable to nonregistry hospitals. Second, although our model adjusted for several patient characteristics and had good discrimination, we did not have information on certain patient factors. For instance, we did not have information on cyanotic and acyanotic congenital heart disease in most patients, which may have improved model discrimination. Moreover, we did not have information on hospital factors, such as staffing ratios, presence of aroundthe-clock intensivists in critical care units, a site's annual cardiac surgery volume, and use of mock codes and other quality improvement initiatives. In addition, our examination of variation in risk-standardized survival rates was limited to 30 hospitals with ≥10 pediatric in-hospital cardiac arrest cases; future studies with a larger hospital sample may be needed to confirm these findings. Last, we did not assess survival with favorable neurological outcomes-another clinically important outcome to patients-as it was missing in 26% of pediatric survivors and was outside the scope of our present study of survival.
Conclusions
In a national registry of in-hospital cardiac arrest, we have developed and validated a model to risk-standardize hospital rates of survival for pediatric in-hospital cardiac arrest. After accounting for patient case-mix, we found that variation in hospital survival rates decreased but persisted. Our findings lay the methodological foundation for future efforts by national organizations to benchmark hospital survival for cardiac arrest in children and suggest the possibility that differences in hospital processes and quality of care, in part, account for the differences in survival rates across hospitals.
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